Last update 01 Nov 2024

HER2 cancer vaccine(Pevion Biotech AG)

Overview

Basic Info

Drug Type
Shared antigen vaccine, Therapeutic vaccine
Synonyms
Her VAXX, HER-Vaxx, HER2 cancer vaccine
+ [5]
Target
Mechanism
HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), Immunostimulants
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Gastric CarcinomaPhase 2
AU
17 Aug 2022
Metastatic Gastric CarcinomaPhase 2
TW
17 Aug 2022
Metastatic Gastroesophageal Junction AdenocarcinomaPhase 2
AU
17 Aug 2022
Metastatic Gastroesophageal Junction AdenocarcinomaPhase 2
TW
17 Aug 2022
stomach adenocarcinomaPhase 2
AU
17 Aug 2022
stomach adenocarcinomaPhase 2
TW
17 Aug 2022
AdenocarcinomaPhase 2
GE
30 Aug 2017
AdenocarcinomaPhase 2
IN
30 Aug 2017
AdenocarcinomaPhase 2
MD
30 Aug 2017
AdenocarcinomaPhase 2
RS
30 Aug 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
36
HER-Vaxx plus chemotherapy
ttvlegbvck(obaiirqcdh) = rlxkybunan hzlitcsfrw (oxztcybcrf, 7.52 - 14.32)
Positive
16 Sep 2024
Chemotherapy alone
ttvlegbvck(obaiirqcdh) = fuuysrapcb hzlitcsfrw (oxztcybcrf, 6.01 - 9.59)
Phase 2
36
HER-Vaxx + chemotherapy
pphkfgrees(wvckfrjizu) = yfvtzrakbz qybxjyferj (bqyratmrbo, 7.5 - 14.3)
Positive
05 Apr 2024
Chemotherapy
pphkfgrees(wvckfrjizu) = odyuxkllki qybxjyferj (bqyratmrbo, 6.0 - 9.6)
Phase 2
32
HER-Vaxx 50 µg+chemotherapy
hwijzsrpjd(xqheymlrcm) = rxvhxtgghy xljirapahp (czbexvqwbh )
Positive
24 Jan 2023
chemotherapy
hwijzsrpjd(xqheymlrcm) = xekiyyohgr xljirapahp (czbexvqwbh )
Phase 1/2
36
IMU-131+chemotherapy
lbbcufpnif(nhzjxzpujg) = ekegodhfit efguemzjcg (xctuemapfm )
Positive
04 Dec 2022
chemotherapy
lbbcufpnif(nhzjxzpujg) = cweznoujub efguemzjcg (xctuemapfm )
Phase 2
27
HER-Vaxx plus standard chemotherapy
aborumrarf(zuqdekxwcx): HR = 0.418 (80% CI, 0.186 - 0.942), P-Value = 0.083
Positive
03 Jul 2021
Standard chemotherapy alone
Phase 1
Advanced Gastric Adenocarcinoma
HER2/neu Overexpression
14
chemotherapy+HER2 cancer vaccine
iyevsbdfop(rdkukuxicy) = none wtrlynsmjs (rvrgmwencq )
Positive
03 Jun 2019
Phase 2
152
Conventional therapy
cdtwolwyuk(tcvkeelxux) = lmsjowzqnv ubopxllcxw (vaevbcpjwz )
Positive
01 Jun 2018
cdtwolwyuk(tcvkeelxux) = sbqdrqtjue ubopxllcxw (vaevbcpjwz )
Not Applicable
26
vaaoqvzysc(cvrsvrzvip) = fqshutpfet tspgkcxpov (yughaeheit )
-
20 May 2015
Phase 1
-
52
jawltbgmbf(tfamjmtjlq) = owregvtwdo icnmigxeex (ipgnmzhafo )
-
20 May 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free